RSSCategory: General Healthcare News

Neagen and Visiopharm Announce New Technical Integration Between Image Analysis and PACS to Meet Demands from Pathologists

| September 10, 2017 | 0 Comments

Workflow, workflow, workflow has been a laboratory mantra for decades. Lean engineering principles, risk reduction, patient safety and efficiencies in every step. And for almost as long it has been recognized in digital pathology that workflow would need to be improved, particularly in “open” systems where best-of-breed may be implemented rather than “closed” systems. One […]

Continue Reading

Where Have all the Informaticists Gone?

| September 6, 2017 | 1 Comment

On a boat on one or more likely all three of the rivers that course through Pittsburgh, circa 1997, as a medical intern I met several folks who were the recognized leaders in pathology informatics. In the years that followed, between other “APIII” meetings as they were then called – “Anatomic Pathology Informatics, Imaging and […]

Continue Reading

Philips Successfully Digitizes Two Pathology Labs in Austria

| August 31, 2017 | 0 Comments

Philips supports global transformation of pathology with two new fully digitized labs in Austria With availability for primary diagnostic use in North-America, Europe and Asia, Philips IntelliSite Pathology Solution is helping labs worldwide to improve the efficiency and quality of cancer diagnostics Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, […]

Continue Reading

A.I Versus M.D. – Part 2

| July 16, 2017 | 0 Comments

In April I wrote a post entitled A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1. This was followed by a guest post by David West, CEO, Proscia, entitled AI vs MD – What it Means for Pathology in May where David, among many issues points out the use […]

Continue Reading

Will Robot Surgeons Provide Better Clinical Histories?

| July 7, 2017 | 0 Comments

Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed “geek physician with a PhD in genomics and Amazon Top 100 author” who envisions “the impact of digital health technologies on the future of healthcare, and helps patients, doctors, government regulators and companies make it a reality” recently shared this infographic on Twitter. Berci has a lot […]

Continue Reading

Pathology Horizons 2017 – The Countdown is On!

| July 3, 2017 | 0 Comments

It is now just six weeks until the Pathology Horizons 2017 conference in Cairns. Places are filling fast, so if you haven’t registered yet, make sure you sign up today. About the conference Pathology Horizons focuses on new technologies, developments and lines of research that will drive the future of pathology. Organised annually by Cirdan, it is a unique […]

Continue Reading

Grail’s Billion Dollar Bet for the Perfect Cancer Test

| June 11, 2017 | 1 Comment

Thought this was worth sharing from MIT Technology Review. After attending ASCO last week what I thought might happen a year or two again actually has. Pathologists no longer have to worry about stepping out from behind the paraffin curtain as many of us were fond of saying. Tissue is not the issue anymore. At […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

Inspirata to Participate in Thought Leadership for Cancer Information Sharing at the Association for Pathology Informatics Annual Summit in Pittsburgh May 22-25

| May 22, 2017 | 0 Comments

Inspirata will showcase its Cancer Diagnostic Cockpit and Consultation Portal as well as present scientific findings on a system that mines relevant information in cancer case reports. Pittsburgh, PA, May 22, 2017 – Cancer diagnostics and pathology workflow solution provider Inspirata®, Inc. announced today that it is exhibiting in booth B2 at the Association for […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

ASI’s HiPath™ For Computer-Assisted PD-L1 Interpretation

| May 12, 2017 | 0 Comments

HiPath™ Supports Pathologists with Advanced Image Analysis of PD-L1 Assays CARLSBAD, CA, May 11, 2017 — Applied Spectral Imaging (ASI), a global leader of computer-assisted microscopy, introduces HiPath imaging and analysis of PD-L1 assays. PD-L1 is seen as the current breakthrough therapeutic target in immuno-oncology. Following recent clinical advances, PD-L1 expression has become a key factor in […]

Continue Reading

Guest Post: AI vs MD – What it Means for Pathology

AI vs MD: What it means for Pathology By David West, CEO, Proscia Will computers replace doctors? It’s the question on everyone’s mind when reading Siddhartha Mukherjee’s article in the New Yorker “AI vs MD”, which pits human doctors against computers. It’s a beautifully composed summary on the role of software algorithms in healthcare, examining […]

Continue Reading

A.I. Versus M.D. – Either Way – Pathologists Do Not Diagnose Cancer – Part 1

| April 3, 2017 | 3 Comments

A loyal reader tipped me off to a recent article in The New Yorker entitled “A.I. Versus M.D.” The article is written by Dr. Siddhartha Mukherjee, a well known oncologist and author of The Emperor of all Maladies. This article, the book and the documentary are all worth reading/viewing if you are not familiar with […]

Continue Reading